Home Economic Development Focus BioSig gaining momentum with proprietary AFib-treating tech

BioSig gaining momentum with proprietary AFib-treating tech

SHARE

“Twenty years from now, most medical decisions will be made by machines,” asserts founder and CEO Ken Londoner.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email